These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study. Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Kimura H; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ Clin Exp Nephrol; 2021 Apr; 25(4):410-417. PubMed ID: 33411113 [TBL] [Abstract][Full Text] [Related]
5. Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney Disease. Garlo KG; Bates DW; Seger DL; Fiskio JM; Charytan DM JAMA Netw Open; 2018 Nov; 1(7):e183874. PubMed ID: 30646338 [TBL] [Abstract][Full Text] [Related]
7. Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease. Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F Nefrologia (Engl Ed); 2019; 39(5):513-522. PubMed ID: 31027897 [TBL] [Abstract][Full Text] [Related]
8. Serum potassium in stage 5 CKD patients on their first presentation in a dialysis service of a county hospital in western Romania. Gluhovschi G; Mateş A; Gluhovschi C; Golea O; Gădălean F; Somai M; Ene I; Petrica L; Velciov S Rom J Intern Med; 2014; 52(1):30-8. PubMed ID: 25000676 [TBL] [Abstract][Full Text] [Related]
9. Potassium abnormalities in current clinical practice: frequency, causes, severity and management. Eliacik E; Yildirim T; Sahin U; Kizilarslanoglu C; Tapan U; Aybal-Kutlugun A; Hascelik G; Arici M Med Princ Pract; 2015; 24(3):271-5. PubMed ID: 25766276 [TBL] [Abstract][Full Text] [Related]
10. Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients - A population-based cohort study. Adelborg K; Nicolaisen SK; Hasvold P; Palaka E; Pedersen L; Thomsen RW PLoS One; 2019; 14(6):e0218739. PubMed ID: 31226134 [TBL] [Abstract][Full Text] [Related]
11. Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study. Leon SJ; Whitlock R; Rigatto C; Komenda P; Bohm C; Sucha E; Bota SE; Tuna M; Collister D; Sood M; Tangri N Am J Kidney Dis; 2022 Aug; 80(2):164-173.e1. PubMed ID: 35085685 [TBL] [Abstract][Full Text] [Related]
13. [Hyperkalemia as a limiting factor in the use of drugs that block the Renin Angiotensin Aldosterone System (RAAS)]. Santoro A; Mandreoli M G Ital Nefrol; 2018 May; 35(3):. PubMed ID: 29786183 [TBL] [Abstract][Full Text] [Related]
14. Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease. Oktaviono YH; Kusumawardhani N Acta Med Indones; 2020 Jan; 52(1):74-79. PubMed ID: 32291375 [TBL] [Abstract][Full Text] [Related]
15. Chronic hyperkalemia in non-dialysis CKD: controversial issues in nephrology practice. De Nicola L; Di Lullo L; Paoletti E; Cupisti A; Bianchi S J Nephrol; 2018 Oct; 31(5):653-664. PubMed ID: 29882199 [TBL] [Abstract][Full Text] [Related]
16. Associations between serum potassium and adverse clinical outcomes: A systematic literature review. Palaka E; Grandy S; Darlington O; McEwan P; van Doornewaard A Int J Clin Pract; 2020 Jan; 74(1):e13421. PubMed ID: 31532067 [TBL] [Abstract][Full Text] [Related]
17. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction. Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475 [TBL] [Abstract][Full Text] [Related]
19. Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes. Collins AJ; Pitt B; Reaven N; Funk S; McGaughey K; Wilson D; Bushinsky DA Am J Nephrol; 2017; 46(3):213-221. PubMed ID: 28866674 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics. Weir MR; Mayo MR; Garza D; Arthur SA; Berman L; Bushinsky D; Wilson DJ; Epstein M J Hypertens; 2017 May; 35 Suppl 1(Suppl 1):S57-S63. PubMed ID: 28129247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]